@misc{indiciae3c84691b2b3e,
  title = {Drug screening identifies the Src/Abl inhibitor Dasatinib as suppressor of IL-23 signalling in skin inflammation},
  author = {Navarro, M. N. and Valle-Pastor, M. J. and Cayuela, I. and Yebra, J. S. and Senach-Rasilla, L. and Pastor-Fernandez, G. and Oliva, A. and Traba, J.},
  year = {2025},
  doi = {10.64898/2025.12.04.692333},
  url = {https://www.biorxiv.org/content/10.64898/2025.12.04.692333v1},
  note = {Source identifier: 10.64898/2025.12.04.692333}
}